The Roche group has signaled a commitment to antibiotics by way of a collaboration with Warp Drive Bio Inc of Cambridge, Massachusetts, US to advance multiple new classes of antibiotic drugs targeting drug-resistant, Gram-negative pathogens. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
